Triple-Negative Breast Cancer | Professor Peter Schmid, MD, PhD

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Triple-Negative Breast Cancer — Faculty Presentation 1: Optimal Integration of Immune Checkpoint Inhibitors into the Management of Metastatic Triple-Negative Breast Cancer — Professor Schmid. CME information and select publications